Docket Management
Docket: 02N-0152 - Timely Pediatric Studies and Adequate Pediatric Labeling for Human Drugs and Biologics
Comment Number: EC -74

Accepted - Volume 3

Comment Record
Commentor Dr. Viking Hedberg Date/Time 2002-07-08 14:27:50
Organization Society for Adolescent Medicine
Category Health Professional

Comments for FDA General
Questions
1. What changes to the pediatric rule, if any, would be necessary to integrate the BPCA and the pediatric rule more effectively? The pediatric rule needs to be preserved. Pediatric patients need to have new drugs tested, and the pediatric rule is the tool that mandates drug companies to fund testing in pediatric populations.




EC -74